Loi S, Michiels S, Adams S, Loibl S, et al. The journey of tumor infiltrating lymphocytes (TIL) as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition. Ann Oncol 2021 Jul 23. pii: S0923-7534(21)02185.
PMID: 34311075